Cytokinetics (CYTK) Change in Acquisitions & Divestments (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Change in Acquisitions & Divestments of $257.9 million for Q1 2026, down 6.45% year-over-year from $275.7 million in Q1 2025, and up 3224125.0% quarter-over-quarter from $8000.0 in Q4 2025.
Cytokinetics (CYTK) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $257.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 6.45% year-over-year to $257.9 million; the TTM figure through Mar 2026 stood at -$11.8 million (down 101.4% YoY), while the FY2025 annual figure was $6.0 million, down 99.19% from the prior year.
- Change in Acquisitions & Divestments rose to $257.9 million in Q1 2026 per CYTK's latest filing, from $8000.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $744.2 million in Q4 2024 and bottomed at -$269.7 million in Q2 2025.
- Historically, Change in Acquisitions & Divestments has averaged $107.8 million across 5 years, with a median of $136.0 million in 2022.
- Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments plunged 280.63% — and 2024, when it jumped 37211350.0%.
- Cytokinetics' Change in Acquisitions & Divestments stood at $157.6 million in 2022, then plunged by 100.0% to -$2000.0 in 2023, then surged by 37211350.0% to $744.2 million in 2024, then slumped by 100.0% to $8000.0 in 2025, then surged by 3224125.0% to $257.9 million in 2026.
- Business Quant data shows CYTK's Change in Acquisitions & Divestments at $257.9 million in Q1 2026, $8000.0 in Q4 2025, and $1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 224.60 Mn |
| Jun 30, 2026 | 224.60 Mn |
| Mar 31, 2026 | 257.94 Mn |
| Mar 31, 2026 | 257.94 Mn |
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -269.73 Mn |
| Jun 30, 2025 | -269.73 Mn |
| Mar 31, 2025 | 275.73 Mn |
| Mar 31, 2025 | 275.73 Mn |
| Dec 31, 2024 | 744.23 Mn |
| Dec 31, 2024 | 744.23 Mn |
| Jun 30, 2024 | -175.30 Mn |
| Jun 30, 2024 | -175.30 Mn |
| Mar 31, 2024 | 175.30 Mn |
| Mar 31, 2024 | 175.30 Mn |
| Dec 31, 2023 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |